tradingkey.logo
tradingkey.logo
Search

CG Oncology Inc

CGON
Add to Watchlist
71.190USD
-1.840-2.52%
Close 07-31 16:00ETQuotes delayed by 15 min
5.57BMarket Cap
LossP/E TTM

CGON Financials

See CG Oncology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

CG Oncology Inc Earnings Date

Latest Release
May 8, 2026
EPS / Forecast
-0.71/-0.58
Revenue / Forecast
1.08M/305.50K
Period
FY2025 Earnings
Revenue(YoY)
4.04M
254.70%
EPS(YoY)
-2.08
-47.84%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Financial Indicators
EPS
-57.52%-0.71
-12.05%-0.52
-87.87%-0.57
-91.63%-0.54
-77.96%-0.45
-32.57%-0.46
-10.15%-0.30
-16.99%-0.28
-30.07%-0.25
-81.31%-0.35
---0.28
---0.24
---0.20
---0.19
Revenue
1982.69%1.08M
409.21%2.32M
3774.42%1.67M
-100.00%0.00
-90.17%52.00K
45500.00%456.00K
377.78%43.00K
--111.00K
172.68%529.00K
--1.00K
--9.00K
--0.00
--194.00K
--0.00
Net Profit
-74.74%-60.20M
-29.91%-41.31M
-114.69%-43.81M
-119.16%-41.43M
-103.47%-34.45M
-44.20%-31.80M
-16.51%-20.41M
-22.83%-18.90M
-36.54%-16.93M
-81.31%-22.05M
---17.51M
---15.39M
---12.40M
---12.16M
Net Margin
91.61%-5558.82%
74.49%-1779.03%
94.46%-2629.53%
----
-1969.94%-66253.85%
99.57%-6973.25%
63.71%-47453.49%
---17028.83%
28.36%-3200.76%
---1611600.00%
---130755.56%
----
---4467.53%
----
Gross Margin
-273.50%-173.50%
-132.21%-32.21%
-94.66%5.34%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
--100.00%
--100.00%
----
--100.00%
----
Debt to assets ratio
--0.26%
--0.38%
--0.41%
----
----
-100.00%0.00%
-100.00%0.00%
--0.00%
--0.00%
--0.18%
--0.18%
----
----
----
Revenue
1982.69%1.08M
409.21%2.32M
3774.42%1.67M
-100.00%0.00
-90.17%52.00K
45500.00%456.00K
377.78%43.00K
--111.00K
172.68%529.00K
--1.00K
--9.00K
--0.00
--194.00K
--0.00
Operating profit
-57.30%-66.39M
-27.99%-48.70M
-80.70%-51.13M
-88.53%-48.74M
-87.83%-42.20M
-100.98%-38.05M
-101.49%-28.30M
-109.74%-25.85M
-131.14%-22.47M
-103.24%-18.93M
---14.04M
---12.33M
---9.72M
---9.31M
Net Profit
-74.74%-60.20M
-29.91%-41.31M
-114.69%-43.81M
-119.16%-41.43M
-103.47%-34.45M
-44.20%-31.80M
-16.51%-20.41M
-22.83%-18.90M
-36.54%-16.93M
-81.31%-22.05M
---17.51M
---15.39M
---12.40M
---12.16M
Current assets
57.18%1.10B
0.70%759.48M
26.03%695.79M
19.36%673.03M
21.19%701.19M
288.52%754.21M
163.26%552.08M
--563.86M
--578.61M
--194.12M
--209.71M
----
----
----
Total current liabilities
55.53%35.22M
44.31%30.84M
95.32%30.53M
156.31%30.38M
126.78%22.64M
49.91%21.37M
33.56%15.63M
--11.85M
--9.98M
--14.25M
--11.70M
----
----
----
Total assets
55.90%1.14B
4.87%791.59M
32.12%729.91M
24.30%701.45M
25.74%728.18M
278.72%754.80M
160.74%552.47M
--564.33M
--579.11M
--199.30M
--211.88M
----
----
----
Total liabilities
85.64%43.48M
82.03%38.99M
169.22%42.27M
159.69%31.09M
130.36%23.42M
47.61%21.42M
30.65%15.70M
--11.97M
--10.17M
--14.51M
--12.02M
----
----
----
Total equity
54.92%1.09B
2.62%752.60M
28.11%687.64M
21.36%670.36M
23.87%704.76M
296.87%733.38M
168.56%536.77M
--552.36M
--568.94M
--184.79M
--199.87M
----
----
----
Net operating income
-94.50%-56.94M
-75.28%-36.22M
-144.32%-38.89M
-73.44%-27.96M
-12.55%-29.28M
-28.65%-20.66M
-29.82%-15.92M
-49.45%-16.12M
-225.72%-26.01M
-135.19%-16.06M
---12.26M
---10.79M
---7.99M
---6.83M
Net investment
-79.28%-334.85M
-792.39%-75.50M
-52.99%15.04M
103.88%1.41M
39.25%-186.77M
-35.64%10.90M
119.83%32.01M
-135.05%-36.23M
-290.66%-307.44M
130.62%16.94M
---161.39M
--103.36M
---78.70M
---55.34M
Net financing
87232.89%393.00M
-55.66%99.07M
2409.00%54.37M
-840.00%-296.00K
-99.89%450.00K
7833.26%223.41M
-97.95%2.17M
100.26%40.00K
52735.03%402.66M
-105.10%-2.89M
--105.88M
---15.22M
---765.00K
--56.70M

FAQs

What is the total revenue of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its total revenue reached 4.04M, with a year-on-year change of 1.14M.

What are the current assets of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its current assets were 759.48M, with a year-on-year change of 0.70.

What are the total assets of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its total assets of CG Oncology Inc were 791.59M, with a year-on-year change of 4.87.

What are the total liabilities of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its total liabilities of CG Oncology Inc were 38.99M, with a year-on-year change of 82.03.

What is the total equity of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its total equity of CG Oncology Inc was 752.60M, with a year-on-year change of 2.62.

What is the net operating income of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its net operating income of CG Oncology Inc was -190.77M, with a year-on-year change of -66.37.

What is the net investment of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its net investment of CG Oncology Inc was -245.82M, with a year-on-year change of 18.27.

What is the net financing of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its net financing of CG Oncology Inc was 153.59M, with a year-on-year change of -75.55.

What is the Earnings Per Share (EPS) of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.08, with a year-on-year change of -47.84.

What is the net income of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its net income was -161.00M, with a year-on-year change of -82.87.

What is the net margin of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its net profit margin was -3985.02, with a year-on-year change of 48.44.

What is the gross margin of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its gross margin was -15.02, with a year-on-year change of -115.02.

What is the Return on Equity (ROE) of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its Return on Equity (ROE) was -21.67, with a year-on-year change of 24.90.

What is the Return on Assets (ROA) of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its Return on Assets (ROA) was -20.82, with a year-on-year change of -12.83.

What is the operating profit of CG Oncology Inc?

According to CG Oncology Inc's FY2025 earnings report, its operating profit was -190.77M, with a year-on-year change of -66.37.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.